Opioid Arrest: Insys Therapeutics founder indicted
PHOENIX (AP) — U.S. prosecutors brought a fraud and racketeering case Thursday against the founder of an opioid medication maker, Insys Therapeutics (NASDAQ:INSY), that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year.
GE explores divesting its transportation, health care IT businesses: Report
General Electric Co is exploring divesting its transportation and health care information technology businesses, as it seeks to reshape its portfolio under new Chief Executive John Flannery, people familiar with the matter said.
Opioid crisis: US pharmacies stock lifesaving overdose antidote
As the White House gets ready to declare the opioid epidemic a public health emergency on Thursday, pharmacies are taking matters into their own hands, stocking an FDA-approved drug that can reverse the effects of an opioid overdose.
Celgene shares crater after 3Q revenue miss, lower forecast
Shares of Celgene are plunging after the drugmaker missed revenue forecasts and dialed back is outlook.
Fisher-Price recalls 65,000 baby seats due to fire hazard
Fisher-Price is voluntarily recalling about 65,000 motorized infant seats because of risk of a fire hazard.
Bristol-Myers misses 3Q profit forecasts
Bristol-Myers Squibb Co. (BMY) on Thursday reported third-quarter earnings of $845 million.
Pfizer to launch consumer health sale in November -sources
Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.
Judge rules Trump does not have to resume health care subsidies
ObamaCare health care subsidies ruling
Judge rejects bid by 18 U.S. states to revive Obamacare subsidies
A U.S. judge in California refused to block President Donald Trump's decision to end subsidy payments to health insurers under Obamacare.
FDA rejects muscular dystrophy drug, says it doesn't work
The U.S. Food and Drug Administration has rejected an experimental drug for a common type of muscular dystrophy.
Ford recalls big vans; wiring issue could cause fires
Ford is recalling over 73,000 full-sized vans in North America to fix a wiring problem that could cause fires and other electrical issues.
US House will not tackle healthcare this year, Ryan says: Reuters
House Speaker Paul Ryan said on Wednesday the Republican-controlled U.S. Congress will not attempt to repeal and replace Obamacare again this year but should try again in 2018.
Drugmaker GSK sees sales rise thanks to new products
Drugmaker GlaxoSmithKline says third-quarter sales rose 4 percent, driven by new products such as the company's Tivicay HIV treatment and Ellipta respiratory therapy.
Anthem's quarterly revenue rises 21%
Anthem reported better-than-expected quarterly profit as the No. 2 U.S. health insurer added more members in its commercial and specialty business and increased its premium rates.
Asian shares inch higher as investors eye corporate earnings
U.S. stocks are edging higher Tuesday morning as construction equipment maker Caterpillar and Post-it note maker 3M lead a rally in industrial companies, while banks are climbing along with interest rates.
Chipotle turnaround stalls as food scares continued
Chipotle said Tuesday that its third-quarter profit nearly tripled and a key sales figure rose, but its adjusted earnings missed Wall Street expectations and its shares fell sharply in after-hours trading.
Caterpillar and 3M jump while Whirlpool tumbles
Stocks that moved substantially or traded heavily Tuesday: Caterpillar Inc., up $6.56 to $138.24
Markets Right Now: Stocks closing higher as Dow sets record
The latest on developments in financial markets (All times local): 9:35 a.m.
US vaccine panel to discuss waning effectiveness, new shots
Two years ago, George Green got stabbing pain and bad blisters around his right arm.
Fiat Chrysler asks for new trial after $40M Jeep fire award
Fiat Chrysler is asking Georgia's highest court for a new trial after the family of a child who died in a Jeep fire was awarded $40 million.












